1

BRIDGING THE GAP 2017 (BTG 2017)

January 12-14, 2017

Swissotel Le Concorde, Bangkok, Thailand

Scientific Meeting Agenda

DAY 1: JANUARY 12, 2017

8:00 AM Inauguration and Opening SpeechDr Surapol Issaragrisil (President, APHCON); Dr Richard Champlin; Dr Morton Coleman; Dr Wichai Prayoonwiwat (President, TSH)

Plenary Session: LymphomaModerator and Chair: Surapol Issaragrisil (Thailand), Richard Champlin (USA)

8:30 AMRevised Classification, New Diagnostic Criteria for Non Hodgkin's LymphomaPei Lin (USA) (20 min)8:50 AMAllogeneic Stem Cell Transplantation for Lymphoma (includes Hodgkin's Lymphoma)Didier Blaise (France) (30 min)9:20 AMImmunotherapy for B-Cell Lymphoma (includes cell therapy)Frederick Hagemeister (USA) (30 min)

10:00 AM Coffee Break and Poster Viewing

Moderator and Chair: Wichai Prayoonwiwat (Thailand), Adolfo de la Fuente (Spain)

10:30 AMAdvances in Peripheral T Cell Lymphoma YL Kwong (Hong Kong) (20 min)10:50 AMNK/T Cell LymphomaWeili Zhao (China) (20 min)11:10 AMAngio-Immunoblastic T Cell LymphomaDaryl Tan (Singapore) (20 min)11:30 AMRole of Transplant in LymphomaNobert-Claude Gorin (France) (20 min)

12:00 PM Lunch

2

1:00 PM Hodgkin's Lymphoma

Moderator: Noppadol Siritanaratkul (Thailand), Frederick Hagemeister (USA)

Newly Diagnosed HLAdolfo de la Fuente (Spain) (15 min)PET Monitoring for Response and Therapy DecisionsPankaj Malhotra (India) (15 min)Relapsed Hodgkin LymphomaFrederick Hagemeister USA (15 min)

2:00 PM Diffuse Large B Cell LymphomaModerator and Chair: Suporn Chuncharunee (Thailand), Govind Babu (India)

Diagnosis and Treatment: Newly Diagnosed DLBCLHemant Malhotra (India)(15 min)Approach to Primary Treatment FailureArchrob Khuhapinant (Thailand) (15 min)Post Auto-Stem Cell Transplant RelapseNobert-Claude Gorin (France) (15 min)Management of CNS involvement in DLBCLGovind Babu (India) (15 min)

3:00 PM - 3:30 PM Coffee Break and Poster Viewing

3:30 PM Low Grade LymphomaModerator and Chair: Wanchai Wanachiwanawin (Thailand), Daryl Tan (Singapore)

Newly Diagnosed Follicular Lymphoma: Chemo vs Targeted Therapy?Daryl Tan (Singapore) (15 min)MRD and Maintenance Therapy for FLAshok Vaid (India) (15 min)Stem Cell Transplant for FLAdolfo de la Fuente (Spain)(15 min)Newly Diagnosed Mantle Cell LymphomaHui Qiang Huang (China) (15 min)

4:30 PM Chronic Lymphocytic LeukemiaModerator and Chair: Apichai Leelasiri (Thailand), Raymond Wong (Hong Kong)

Novel Targeted Therapies for CLLColin Phipps (Singapore) (15 min)Cell Therapy for CLL Frederick Hagemeister (USA) (15 min)Maintenance Therapy in CLLRaymond Wong (Hong Kong) (15 min)

5:30 PM Dinner Symposium

3

DAY 2: JANUARY 13, 2017

Plenary Session

8:00 AM Acute Myeloid Leukemia Moderator and Chair: Borje Andersson (USA), Kaiyan Liu (China)

Ideal Induction Therapy for Newly Diagnosed AML. Do we have a consensus? Jie Jin (China) (20 min)Decision Analysis of Post Remission Therapy for Intermediate Risk AMLKanadit Prayongratana (Thailand)(20 min)Allogeneic Stem Cell Transplant in CR1 for t(8;21) AML Xiao Jun Huang (China) (20 min)Advances in Treatment for Elderly AMLWilliam Hwang (Singapore)(20 min)

9:30 AM Kian Ang Memorial Lecture Moderator and Chair: Borje Andersson (USA) and Panya Seksan (Thailand)

Autologous Stem Cell Transplantation for Adult Acute Leukemia in 2015: Time to Rethink? Present Status and Future ProspectsNobert-Claude Gorin (France)(25 min)

10:00 AM Best Oral Abstract PresentationModerator and Chair: Frederick Hagemeister (USA), Vikram Mathews (India)

Top 2 selected abstracts at 10 minutes each

10:30 AM Coffee Break and Poster Viewing

11:00 AM Acute Lymphocytic Lymphoma Moderator and Chair: Xiao Jun Huang (China), William Hwang (Singapore)

Update on Allogeneic Stem Cell Transplant in ALL Sachiko Seo (USA)(20 min)CAR19-T Cell Adoptive Therapy for B-ALLXiangyu Zhao (China)(20 min)Personalized Therapy in Pediatric ALL Allen Yeoh (Singapore) (20 min)

12:00 PM Lunch

1:00-5:00 PM Benign Hematology 1:00-5:00 PM Malignant Hematology

1:00 PM Aplastic AnemiaModerator and Chair:Surapol Issaragrisil (Thailand), Pankaj Malhotra (India)Non Transplant TherapiesSuporn Chuncharunee (Thailand) (15 min)

1:00 PM Acute Myeloid LeukemiaModerator and ChairArtit Ungkanont (Thailand), Weili Zhao (China)Determining and Monitoring MRDPei Lin (USA) (15 min)

4

Donor Selection and Conditioning RegimenRichard Champlin (USA) (15 min)Case Discussion(15 min)

2:00 PM ThalassemiaModerator and Chair:Suradej Hongeng (Thailand), Borje Andersson (USA)Iron Overload and Novel TherapyVip Viprakasit (Thailand) (15 min)Transplant UpdatesSuradej Hongeng (Thailand) (15 min)Case Discussion(15 min)

3:00 PM Coffee Break and Poster Viewing

Biphenotypic AMLDepei Wu (China) (15 min)FLT3 Positive AMLVikram Mathews (India) (15 min)

2:00 PM Chronic Myelogenous LeukemiaModerator and Chair:Tontanai Numbenjapol (Thailand), Hemant Malhotra (India)Newly Diagnosed CMLQian Jiang (China) (15 min)Relapsed CMLDong Wook Kim (S. Korea) (15 min)Allogeneic Stem Cell Transplant and NK Cell TherapyRichard Champlin (USA) (15 min)

3:15 PM Immune ThrombocytopeniaModerator and Chair:Theera Ruchutrakool (Thailand), Pankaj Malhotra (India)How to Treat Newly Diagnosed ITPRaymond Wong (Hong Kong) (15 min)Treatment of Relapsed/ Refractory ITPPonlapat Rojnuckarin (Thailand) (15 min)Thrombocytopenic Syndrome in PregnancyTheera Ruchutrakool (Thailand) (15 min)

4:15 PM HemophiliaModerator and ChairAmpaiwan Chuansumrit (Thailand), Vikram Mathews (India)Standard of Care and Assessment for HemophiliaAmpaiwan Chuansumrit (Thailand) (15 min)Novel Treatment Using EmcizumabKeiji Nogami (Japan) (15 min)Genetic Mutations in HemophiliaObjoon Trachoo (Thailand) (15 min)

3:15 PM Donor selectionModerator and ChairPiyanuch Kongtim (Thailand), Richard Champlin (USA)Haplo vs. MUDBorje S. Andersson (USA) (15 min)Haplo vs. CordDidier Blaise (France) (15 min)Managing Donor HLA AntibodiesPiyanuch Kongtim (Thailand) (15 min)

4:15 PM Graft versus Host DiseaseModerator and Chair:Udomsak Bunworasate (Thailand), Depei Wu (China)Post-Transplant Cy vs. ATG for Haplo TransplantDidier Blaise (France) (15 min)Risk Stratified Corticosteroids for Haplo TransplantXiao Jun Huang (China) (15 min)Cell Therapy for GVHDSimrit Parmar (USA) (15 min)

5:30 PM APHCON President Dinner Reception

5

DAY 3: JANUARY 14, 2017

Plenary Session: Multiple Myeloma (Open forum with interactive Q and A session)

Moderator and Chair: Robert Orlowski (USA), Lalita Norasetthada (Thailand)8:00 AMConsensus Guidelines for Diagnosis and Response. Elisabeth Mansanch (USA) (20min)8:20 AMFrontline Therapy for Transplant Eligible Patients: Doublet, Triptlet, Quadruplet. Robert Orlowski (USA) (20 min)8:40 AMAutologous Stem Cell Transplant and Post-Transplant MaintenanceSimrit Parmar (USA) (20 min)9:00 AMFrontline Therapy for Transplant In-eligible Patients. Juan Li (China) (20 min)

9:30 AM Coffee Break

Moderator and Chair: James CS Chim (Hong Kong), Weerasak Nawarawong (Thailand)

10:00 AMDefining Relapse: Biochemical vs. Symptomatic. When to increase the dose? When to switch therapy? Jeffery Huang (Taiwan) (20 min)10:20 AMChoice of Therapy for Relapsed Myeloma. James CS Chim (Hong Kong) (20 min)10:30 AMChanging Landscape of Myeloma Therapy: Focus on Proteasome Inhibitors. Robert Orlowski (USA) (20 min)10:50 AMChanging Landscape of Myeloma Therapy: Focus on ImmunotherapySimrit Parmar (USA) (20 min)11:10 AMChanging Landscape of Myeloma Therapy: Focus on Cell Therapy Richard Champlin (USA) (20 min)11:30 AMManagement of Non-Secretory Myeloma Jin Lu (China) (20 min)11:50 AMCase Discussion

12:30 PM Adjourn